LEMAITRE VASCULAR, INC. Deferred Income Tax Expense (Benefit)
LEMAITRE VASCULAR, INC. (LMAT) reported Deferred Income Tax Expense (Benefit) of $2.31 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-26
- LEMAITRE VASCULAR, INC. deferred income tax expense (benefit) for the quarter ending 2013-12-31 was $274.00K.
- LEMAITRE VASCULAR, INC. deferred income tax expense (benefit) for the quarter ending 2012-03-31 was $4.00K.
- LEMAITRE VASCULAR, INC. deferred income tax expense (benefit) for the quarter ending 2010-12-31 was -$2.61M.
- LEMAITRE VASCULAR, INC. deferred income tax expense (benefit) for the quarter ending 2010-09-30 was $94.00K.
- LEMAITRE VASCULAR, INC. deferred income tax expense (benefit) for fiscal 2025 was $2.31M.
- LEMAITRE VASCULAR, INC. deferred income tax expense (benefit) for fiscal 2024 was -$451.00K, a 157.60% decline from fiscal 2023.
- LEMAITRE VASCULAR, INC. deferred income tax expense (benefit) for fiscal 2023 was $783.00K.
- LEMAITRE VASCULAR, INC. deferred income tax expense (benefit) for fiscal 2022 was -$182.00K, a 330.38% decline from fiscal 2021.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.31M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | -$451.00K 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $783.00K 10-K · filed 2026-02-26 | |||
| 2022-12-31 | -$182.00K 10-K · filed 2025-02-28 | |||
| 2021-12-31 | $79.00K 10-K · filed 2024-02-29 | |||
| 2020-12-31 | -$328.00K 10-K · filed 2023-03-01 | |||
| 2019-12-31 | $824.00K 10-K · filed 2022-02-28 | |||
| 2018-12-31 | -$2.15M 10-K · filed 2021-03-12 | |||
| 2017-12-31 | $300.00K 10-K · filed 2020-03-12 | |||
| 2016-12-31 | $140.00K 10-K · filed 2019-03-11 | |||
| 2015-12-31 | -$384.00K 10-K · filed 2018-03-09 | |||
| 2014-12-31 | -$72.00K 10-K · filed 2017-03-09 | |||
| 2013-12-31 | $274.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $287.00K 10-K · filed 2016-03-10 | ||
| 2013-09-30 | $13.00K 10-Q · filed 2014-11-06 | |||
| 2012-12-31 | $287.00K 10-K · filed 2015-03-18 | |||
| 2012-03-31 | $4.00K 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $1.16M 10-K · filed 2014-03-21 | |||
| 2010-12-31 | -$2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27 | -$2.52M derived: sum of 2 quarters · filed 2013-03-27 | -$2.38M 10-K · filed 2013-03-27 | |
| 2010-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $234.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $140.00K 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $226.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |